STOCK TITAN

GraniteShares YieldBOOST CRCL ETF Stock Price, News & Analysis

CRY NASDAQ

Company Description

GraniteShares YieldBOOST CRCL ETF (NASDAQ: CRY) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.

CRY stock has declined 10.8% over the past year. Shares last traded at $22.22.

This page provides a comprehensive overview of CRY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$22.60
-0.70%
0.16
Last updated: June 5, 2026 at 16:37
-10.76%
Performance 1 year

GraniteShares YieldBOOST CRCL ETF (CRY) stock last traded at $22.22, down 0.70% from the previous close. Over the past 12 months, the stock has lost 10.8%.

Latest News

GraniteShares YieldBOOST CRCL ETF has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, earnings, management. View all CRY news →

SEC Filings

No SEC filings available for CRY.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CRY Company Profile & Sector Positioning

GraniteShares YieldBOOST CRCL ETF (CRY) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of GraniteShares YieldBOOST CRCL ETF (CRY)?

The current stock price of GraniteShares YieldBOOST CRCL ETF (CRY) is $22.22 as of June 5, 2026.